Anatomic site based ploidy analysis of oral premalignant lesions

Head and Neck Pathology

Volumn 4, Issue 1, 2010, Pages 10-14

  Islam, M N ^a   Kornberg, L ^b   Veenker, E ^b   Cohen, D M ^c   Bhattacharyya, I ^c  

^a INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

Aneuploid; Dysplasia; Oral leukoplakia; Ploidy

Indexed keywords

DNA; FUCHSINE;

ANEUPLOIDY; ARTICLE; FEMALE; FEULGEN STAINING; GENETICS; HUMAN; IMAGE CYTOMETRY; LEUKOPLAKIA; MALE; MOUTH; MOUTH TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ANEUPLOIDY; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; HUMANS; IMAGE CYTOMETRY; LEUKOPLAKIA; MALE; MOUTH; MOUTH NEOPLASMS; RETROSPECTIVE STUDIES; ROSANILINE DYES;

EID: 77952888219     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-009-0151-0     Document Type: Article

References (27)

1. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978; 46(4): 518-39.
2. Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axell T, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103(Suppl: S19): e1-12.
3. Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F. Potentially malignant oral lesions in northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001; 7(1): 18-24.
4. Feller L, Altini M, Slabbert H. Pre-malignant lesions of the oral mucosa in a South African sample-a clinicopathological study. J Dent Assoc S Afr. 1991; 46(5): 261-5.
5. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002; 52(4): 195-215.
6. Pindborg JJ, Renstrup G, Poulsen HE, Silverman S Jr. Studies in oral leukoplakias v. clinical and histologic signs of malignancy. Acta Odontol Scand. 1963; 21: 407-14.
7. Shafer WG, Waldron CA. A clinical and histopathologic study of oral leukoplakia. Surg Gynecol Obstet. 1961; 112: 411-20.
8. Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias. Cancer. 1975; 36(4): 1386-92.
9. Zhang L, Cheung KJ Jr, Lam WL, Cheng X, Poh C, Priddy R, et al. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer. 2001; 91(11): 2148-55.
10. Curfman GD, Morrissey S, Drazen JM. Retraction: Sudbo J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001; 344: 1270-8 and Sudbo J et al. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004; 350: 1405-13. N Engl J Med. 2006; 355(18): 1927.
11. Betz CS, Stepp H, Janda P, Arbogast S, Grevers G, Baumgartner R, et al. A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis. Int J Cancer. 2002; 97(2): 245-52.
12. Lee BK, Diebel E, Neukam FW, Wiltfang J, Ries J. Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer. Int J Oncol. 2001; 19(5): 1063-8.
13. Soukos NS, Hamblin MR, Keel S, Fabian RL, Deutsch TF, Hasan T. Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res. 2001; 61(11): 4490-6.
14. Lo Muzio L, Pannone G, Leonardi R, Staibano S, Mignogna MD, De Rosa G, et al. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res. 2003; 82(11): 923-8.
15. Lopez M, Aguirre JM, Cuevas N, Anzola M, Videgain J, Aguirregaviria J, et al. Gene promoter hypermethylation in oral rinses of leukoplakia patients-a diagnostic and/or prognostic tool? Eur J Cancer. 2003; 39(16): 2306-9.
16. Hogmo A, Munck-Wikland E, Kuylenstierna R, Lindholm J, Auer G. Nuclear DNA content and p53 immunostaining in metachronous preneoplastic lesions and subsequent carcinomas of the oral cavity. Head Neck. 1996; 18(5): 433-40.
17. Abou-Elhamd KE, Habib TN. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma. Oral Oncol. 2007; 43(4): 366-72.
18. Hogmo A, Lindskog S, Lindholm J, Kuylenstierna R, Auer G, Munck-Wikland E. Preneoplastic oral lesions: the clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression. Anticancer Res. 1998; 18(5B): 3645-50.
19. Kim J, Shin DM, El-Naggar A, Lee JS, Corrales C, Lippman SM, et al. Chromosome polysomy and histological characteristics in oral premalignant lesions. Cancer Epidemiol Biomarkers Prev. 2001; 10(4): 319-25.
20. Klanrit P, Sperandio M, Brown AL, Shirlaw PJ, Challacombe SJ, Morgan PR, et al. DNA ploidy in proliferative verrucous leukoplakia. Oral Oncol. 2007; 43(3): 310-6.
21. Maraki D, Becker J, Boecking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med. 2004; 33(7): 398-404.
22. Remmerbach TW, Weidenbach H, Hemprich A, Bocking A. Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry: report on four cases. Anal Cell Pathol. 2003; 25(4): 159-66.
23. Cahill DP, da Costa LT, Carson-Walter EB, Kinzler KW, Vogelstein B, Lengauer C. Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics. 1999; 58(2): 181-7.
24. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998; 396(6712): 643-9.
25. Sen S. Aneuploidy and cancer. Curr Opin Oncol. 2000; 12(1): 82-8.
26. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer. 1999; 25(3): 195-204.
27. Faranda A, Costa A, Canova S, Abolafio G, Silvestrini R. Image and flow cytometric analyses of DNA content in human solid tumors. A comparative study. Anal Quant Cytol Histol. 1997; 19(4): 338-44.